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Traits associated with central pain augmentation in
the Knee Pain In the Community (KPIC) cohort
Kehinde Akin-Akinyosoyea,b,*, Nadia Frowda,b, Laura Marshalla,b, Joanne Stocksa,b, Gwen S. Fernandesa,b,c,
Ana Valdesa,b,d, Daniel F. McWilliamsa,b, Weiya Zhanga,b,d, Michael Dohertya,b,d, Eamonn Fergusona,e,
David A. Walsha,b,d
Abstract
This study aimed to identify self-report correlates of central pain augmentation in individuals with knee pain. A subset of participants
(n5 420) in the Knee Pain and related health In the Community (KPIC) baseline survey undertook pressure pain detection threshold
(PPT) assessments. Items measuring specific traits related to central pain mechanisms were selected from the survey based on
expert consensus, face validity, item association with underlying constructs measured by originating host questionnaires, adequate
targeting, and PPT correlations. Pain distribution was reported on a body manikin. A “central pain mechanisms” factor was sought
by factor analysis. Associations of items, the derived factor, and originating questionnaires with PPTs were compared. Eight self-
report items measuring traits of anxiety, depression, catastrophizing, neuropathic-like pain, fatigue, sleep disturbance, pain
distribution, and cognitive impact were identified as likely indices of central pain mechanisms. Pressure pain detection thresholds
were associated with items representing each trait and with their originating scales. Pain distribution classified as “pain below the
waist additional to knee pain” was more strongly associated with low PPT than were alternative classifications of pain distribution. A
single factor, interpreted as “central pain mechanisms,” was identified across the 8 selected items and explained variation in PPT
(R25 0.17) better than did any originating scale (R25 0.10-0.13). In conclusion, including representative items within a composite
self-report tool might help identify people with centrally augmented knee pain.
Keywords: Knee pain, Phenotypes, Central mechanisms, Quantitative sensory testing
1. Introduction
Knee pain is a major source of disability, and in people aged over
50 years is most commonly attributed to osteoarthritis (OA).60
Osteoarthritis pain is perceived as originating from the joint, often
associated with structural changes or inflammation, and exacer-
bated by joint loading and movement. However, OA pain is often
troublesome even in the absence of severe radiographic
change,24 and might persist after removal of the peripheral
nociceptive drive, with persistent pain being reported by 10% to
20% of people after total knee replacement for knee OA.4,79,80
Evidence from mechanistic (ie, experimental pain testing and
functional neuroimaging studies)25,30,33,59,60,69 and therapeutic
trials11,29 indicates that the central nervous system (CNS) might
amplify neural signalling and influence OA knee pain sensitivity,
leading to central pain augmentation.42,78 Optimal management
of OA knee pain therefore requires that underlying pain
mechanisms be identified in each individual.3
Quantitative sensory testing can indicate changes in pain
sensitivity. Pressure pain detection thresholds (PPTs) might be
reduced at a site of clinical pain, suggesting neuronal sensitization
of the affected area. More widespread increased sensitivity at
pain-free control sites is suggestive of altered pain processing in
the CNS.16,31 In animal models of OA, pain sensitivity (reduced
withdrawal thresholds to punctate stimulation) at a site distal to
the affected knee (hindpaw) is characterized by spinal hyperex-
citability of neurons innervating sites distal to the affected
joint.23,56,63,64 Furthermore, pain sensitivity distal to the affected
joint in people with OA has been associated with changes to
descending pain control mechanisms,33 as hasmorewidespread
pain (WSP) in people with fibromyalgia.5
Individual differences in distinct observable traits (phenotypes),
measured by questionnaires addressing depression, anxiety,
catastrophizing, neuropathic-like pain, or WSP, have been
associated with knee pain severity.10,16,35,39,62,67,68 Each of
these traits might also be associated with markers of central pain
mechanisms.6,7,36,45,46,49,51,62,71 High scores on these ques-
tionnaires, and low PPTs, have each predicted poor outcome
after treatment directed to the painful joint,2,59,60,79,80 raising the
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possibility that treatments directed to central pain mechanisms
might be useful for those patients. Using a full battery of existing
questionnaires plus PPT measurement would be resource-
intensive during normal clinical encounters. A concise composite
self-report tool is needed to help identify people with centrally
augmented knee pain.
We hypothesise that each of these traits might reflect aspects
of central pain mechanisms. By combining evidence from expert
opinion and statistical analysis of questionnaire data from
a community-based study in people with knee pain, we aimed
to identify a concise, yet psychometrically reliable and valid set of
self-report questions that measure a phenotypic trait associated
with central pain augmentation, as indicated by reduced PPT at
the proximal tibia, a site distal to the painful knee.
2. Methods
2.1. Study population
Participants aged 40 years or older provided baseline data within
the Nottinghamshire community-based Knee Pain and Related
Health in the Community study (KPIC) cohort study.22 Ques-
tionnaires factor structure was confirmed using data from 2512
participants who reported current knee pain (616 10 years, 57%
female). A purposive subset of KPIC participants (n 5 420)
underwent further clinical, PPT, and radiographic assessments.22
This subset comprised people with no knee pain (n5 98), or pain
for ,3 years (n 5 219) or .3 years (n 5 103). The KPIC study
protocol (clinicaltrials.gov portal: NCT02098070) was approved
by the Nottingham Research Ethics Committee 1 (NREC Ref: 14/
EM/0015) and all participants provided informed written consent.
2.2. Self-report questionnaires
Presence of current knee painwas determined by response to the
question: “Have you had knee pain for most days of the past 1
month?”61,74
Participants reporting knee pain indicated the affected knee if
unilateral, or the worst affected knee if bilateral.
The KPIC baseline survey included established self-report
questionnaires for neuropathic-like pain (painDETECT modified for
use in people with knee OA),39 intermittent and constant OA knee
pain (ICOAP),37 catastrophic thinking (Pain Catastrophizing Scale
[PCS]),72 and anxiety and depression (Hospital Anxiety and De-
pression Scale [HADS]).81 Traits of fatigue, cognitive impact,65 and
pain distribution40 were each measured by single items. Rasch‐
transformed questionnaire scores were used when previously
validated in knee pain cases (painDETECT and ICOAP),37,39 other-
wisenontransformedscoreswereused (HADSandPCS). Itemswere
coded so that higher scores represented greater pain or distress.
Pain distribution was captured using areas shaded by the
participant on a bodymanikin. The manikin was coded according
to shading in 7 and 25 topographical areas.15,77 Pain distribution
was also categorized using American College of Rheumatology
Widespread Pain (ACR’s WSP) criteria,77 and based on the
presence or absence of pain (1) contralateral to the index knee, (2)
above the waist, (3) below the waist, or (4) axial.
2.3. Pressure pain detection thresholds
The PPT wasmeasured using a hand-held pressure algometer with
a circular (1 cm2) padded-tipped probe connected to a computer
(HP ProBook 4520s), with outputs computer analysed by dedicated
software (Somedic AB, Sweden). Pressure was applied with
a standardised 30 kPa/s ramp until the participant indicated by
pressing a button, a change from pressure to pain sensation.
Participants were familiarised before testing by twice PPT testing on
a fingernail of the dominant hand. Each PPT testing cycle was
conducted at the sternum (3-cm caudal to the sternal notch), the
medial and lateral tibiofemoral joint lines adjacent to the patellar
ligament of each knee, and the proximal tibia (5-cm distal to the tibial
tuberosity of each leg). The PPT cycle was repeated 3 times with
a 2-minute rest period between each cycle. Pressure pain detection
threshold values (kPA) for each site were averaged across the 3
cycles. Pressure pain detection threshold assessments for each
participant were undertaken using a standardized protocol by 1 of 2
trained researchers, blinded to participant characteristics including
pain status.22
Raw PPT values were not normally distributed, thus PPTs were
logarithmically transformed before statistical analysis to achieve
normality of the data, and normality confirmed using the
Shapiro–Wilk test.
Pressure pain detection threshold values served as a reference
test during receiver-operating curve analysis to identify the
number of painful sites other than the knee, reported on the
body pain manikin that is indicative of central pain mechanisms.
Preliminary analysis demonstrated no significant differences in
PPT between participants with or without knee pain, and
therefore, standardized z-scores were computed from log PPT
data for all 420 participants. Pressure pain detection threshold
values below the 10th percentile (z . 1.28) were classified as
abnormally increased sensitivity (gain-of-function) at the mea-
sured site.14 Number of painful sites were selected that
maximized sensitivity while maintaining a minimum specificity of
0.75 for predicting PPT gain-of-function.54
Unless otherwise stated, results are reported in the main text
for primary analyses using PPTs (after log-transformation) at the
proximal tibia distal to the participant’s worst affected knee, taken
to be an index for centrally augmented pain.73 Results for
secondary analyses using PPT measured at other sites are
reported within the supplementary tables (available online at
http://links.lww.com/PAIN/A543).
2.4. Item selection
We used a sequential strategy to select items representing traits
reflecting central pain mechanisms (Fig. 1):
(1) Items not relevant to the study hypothesis were excluded, after
initial screening by the research team.
(2) Where items originated from established questionnaires (PCS,
HADS, painDETECT, and ICOAP), the 2 items were selected with
highest loading to each questionnaire’s latent constructs. Item
loading was determined by exploratory structural equation
modelling (ESEM)18 across each questionnaire, using data from
KPIC participants who reported current knee pain (n5 2152).
(3)Items were excluded if there was below moderate expert
agreement (k* , 0.60) on their relevance to central mecha-
nisms of knee pain.12,27 Invited experts comprised experi-
enced clinical and research experts (n 5 25) across various
pain research disciplines (orthopaedics, rheumatology, sports
and exercise medicine, psychology, neuroscience, physio-
therapy, pharmacy, genetics, and musculoskeletal epidemiol-
ogy) within the Arthritis Research UK (ARUK) Pain Centre.
Experts indicated relevance for each item using a 4-point Likert
scale (0 “not relevant” to 3 “highly relevant”).
(4)The percentage of respondents selecting each response
category for an item was examined to ensure adequate
targeting (a balanced frequency (%) of selection for each
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response category provided for an item across a study
population). Items were excluded if any single response
category was selected by $80% of participants.8,47
(5) Items were excluded if associations with PPT at the proximal
tibia were not statistically significant. The PPT at the proximal
tibia (an unaffected site, distal to the affected knee) was taken
to be indicative of central pain mechanisms.73 Lack of
a relationship between a self-report item and PPT was taken
to indicate that the item might itself, not be indicative of central
pain mechanisms.
2.5. Data analysis
Pressure pain detection threshold homogeneity was assessed
using concordance correlation coefficient (CCC) to establish
intrarater and interrater agreement for the 2 PPT assessors.43
Associations between PPT and questionnaire data in partic-
ipants with knee pain (n 5 322) are presented as Spearman
correlation coefficients (r) or standardized regression coefficients
(b) from linear regression models. Adjusted P values were
obtained using Bonferroni correction. All analyses used complete
case data because of low levels of missing data.
2.5.1. Validation of selected items
For factor analysis of the selected items, participantswith kneepain
who had undergone PPT assessment (n 5 322) were randomly
allocated into 2 equal groups using Stata, version 14.2,70 to avoid
spurious or chance effects.28 Exploratory structural equation
modelling was used with 1 group and the resulting model was
tested in the other group using confirmatory factor analysis (CFA).
Pressure pain detection threshold variance explained by the
identified factor(s) in fully adjusted models (adjusted for age, sex,
and body mass index [BMI]) were compared with the variance
explained by the host scales. To explore equivalence of the
identified factor(s) and selected items with respect to age, sex, and
BMI, Multiple-Indicator Multiple-Causal (MIMIC) models were
used. MIMIC models are a type of CFA model where the latent
factors and the items are simultaneously regressed on to
demographics and other relevant covariates.57
We further sought to determine whether traits represented by
the host scale explained the associations between PPT and items
selected from that scale. Derived scale scores for each host scale
were calculated by subtracting “the score for each selected item”
from “the summary score for the respective host scale.” Each
model testing the association between PPT and a selected item,
or between PPT and any identified factor(s), was adjusted for
derived scale scores.
Analyses were performed using Stata, version 14.2,70 except
that ESEM and CFA used MPlus, version 7.4.52 Except where
stated, all analyses were conducted within the participant group
that reported knee pain and who had undergone PPT assess-
ment (n 5 322). Demographics are presented as mean (SD) or
median (interquartile range). Between-group comparisons used
Student t test and, where appropriate, 95% confidence intervals
(CIs) are presented.
3. Results
3.1. Study population
The 322 participants with knee pain were on average 59 (SD 10)
years of age, had an average BMI of 29 (SD 7), and most were
female (61%). Participants without knee pain (n 5 98, 60%
female, age 606 10 years) displayed geometric mean PPT at the
proximal tibia of 383 (95% CI 169-780) kPA, similar to those with
knee pain (358 [95% CI 134-871] kPa, P 5 0.27).
Demographic and clinical characteristics for the knee pain
group are presented in Table 1.
Figure 1. Flow chart showing the item selection process across traits. ESEM, exploratory structural equation modelling; PPT, pressure pain detection threshold.
#Only relevant for items originating from established questionnaires measuring specific traits.
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3.2. Pressure pain detection thresholds
Pressure pain detection thresholds at the proximal tibia displayed
moderate interrater reliability (CCC5 0.51) and intrarater reliability
(CCC 5 0.60) (Supplementary Table 1, available online at
http://links.lww.com/PAIN/A543). Lower PPTs were associated
with female sex (females; 314 [287-343] kPa,males; 428 [391-473]
kPa, P, 0.0001) and higher BMI (r520.19, P5 0.002), but not
with age (r520.01, P5 0.83). For those with knee pain, PPTwas
not associated with radiographic x-ray scores (r 5 20.041, P 5
0.491), but was associated with a painDETECT measure of knee
pain severity (“How would you rate your most painful knee pain on
a 0 to 10 scale at the present time, ie, right now”) (r520.18, P5
0.002). Pain severity showed a weak but significant relationship
with radiographic scores (r 5 0.15, P 5 0.007).
3.2.1. Pain distribution
The number of other sites reported as painful in addition to knee
pain was negatively correlated with PPT distal to the index knee
(23 other sites: r 5 20.16, P 5 0.008; 7 other sites: r 5 20.16,
P5 0.007). Cutoff points of$5/7 or$6/23 painful sites additional
to knee, optimally predicted low PPT (specificity .0.75 and
accuracy 73.4%). “Knee pain plus other pain below the waist”
showed significant association with PPT (b 5 20.14; P , 0.02),
but other pain distribution categories did not (Table 2). ACRWSP
classification did not significantly predict PPT, whether including
(b520.03, P5 0.55) or excluding (b520.05; P5 0.37) knees
as painful sites. The presence of “knee pain plus other pain below
thewaist” was selected for further analyses over “number of sites”
criteria because of ease of application.
3.3. Item selection
Twenty-five items potentially reflecting central mechanisms were
selected for expert review. Exploratory structural equation
modelling confirmed 11 latent factors from 4 questionnaires,
representing anxiety or depression (HADS), magnification or
rumination (PCS), pain intensity, evoked or spontaneous
Table 1
Baseline demographics and clinical characteristics of participants with knee pain.
Knee pain sample P
Overall (n 5 322) Exploratory (n 5 168) Confirmatory (n 5 154)
Sex; n (%) female 197 (61%) 99 (50%) 98 (50%) 0.38
Age; mean 6 SD, y 59.4 6 9.5 59.9 6 9.7 59.9 6 9.8 0.98
BMI; mean 6 SD, kg/m2 29.5 6 6.1 29.3 6 5.6 30.0 6 6.5 0.30
Proximal tibia PPT, kPA 372 (265-528) 391 (268-523) 361 (249-528) 0.96
Tibiofemoral KL $2; n (%) 96 (30%) 55 (33%) 41 (27%) 0.22
Questionnaire scores
Constant pain-ICOAP (possible range 0-24) 6 (3-11) 6 (3-11) 6 (3-12) 0.75
Intermittent pain-ICOAP (possible range 0-
22)
8 (5-14) 8 (5-14) 9 (5-14) 0.94
Modified PainDETECT (possible range 21 to
38)
9 (5-14) 9 (5-14) 9 (5-14) 0.56
Pain catastrophizing scale (possible range 0-
52)
8 (3-20) 8 (3-20) 8 (3-19) 0.83
Anxiety-HADS (possible range 0-14) 6 (4-10) 6 (4-9) 7 (4-10) 0.09
Depression-HADS (possible range 0-14) 5 (3-8) 4 (3-8) 5 (3-8) 0.78
Data are median (interquartile ranges [IQRs]) except where indicated. Sex, age, body mass index (BMI), and geometric mean of log-transformed pressure pain detection thresholds (PPTs) are given for all 322 cases.
Questionnaire data are presented where complete data available (constant-Intermittent and Constant Osteoarthritis Pain scale [ICOAP] n5 280; intermittent-ICOAP n5 296; Anxiety-Hospital Anxiety and Depression scale
[HADS] n 5 315; Depression-HADS n 5 314; Pain Catastrophizing Scale [PCS], n 5 314; and Modified PainDETECT Questionnaire n 5 282).
Table 2
Pressure pain detection thresholds (PPTs) at the proximal tibia are predicted by ROC- and a priori-binarymanikin classifications
in individuals within the knee pain sample (n 5 322).
n (%) b (95% CI) b P
ROC-derived classifications
$5/7 other sites 62 (19%) 20.20 (20.37 to 20.03) 20.14 0.02
$6/23 other sites 86 (27%) 20.19 (20.34 to 20.04) 20.14 0.01
A priori classifications
Above waist 189 (59%) 20.08 (20.22 to 20.06) 20.07 0.26
Below waist 169 (52%) 20.17 (20.30 to 20.03) 20.14 0.02
Contralateral to index knee 119 (37%) 20.14 (20.28 to 0.002) 20.12 0.05
Axial pain 151 (47%) 20.01 (20.15 to 0.12) 20.01 0.87
Widespread pain* 31 (10%) 20.08 (20.34 to 0.18) 20.03 0.55
Classifications are based on number or distribution of painful sites in addition to knee pain reported by participants on a body manikin.
Bold indicates statistically significant associations.
Proportion (n, %) of participants with knee pain reporting other pain according to classifications is presented.
Unstandardized (b) and standardized (b) regression coefficients are presented.
* Widespread pain, classified according to American College of Rheumatology criteria,37 including knee pain.
CI, confidence interval; ROC, receiver-operating curve.
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neuropathic-like pain (painDETECT), and psychological or
somatic effects of pain (both in each of the ICOAP Constant
and Intermittent ICOAP subscales) (Supplementary Tables 2–6,
available online at http://links.lww.com/PAIN/A543). Two items
were selected with highest loading to each of these factors.
Additional items measured traits of fatigue, cognitive impact, and
pain distribution (pain manikin). Sixteen (64%) experts responded
to the consensus task and displayed moderate to excellent
agreement (k. 0.6) for relevance of 19 of the 25 items to central
pain mechanisms (Table 3).
Supplementary Table 7 gives item response distributions in
people with knee pain (available online at http://links.lww.com/
PAIN/A543). Each scale was positively associated with scores on
other scales (r 5 0.23-0.63, P , 0.05, Supplementary Table 8,
available online at http://links.lww.com/PAIN/A543). The 19
items selected after expert review also all displayed significant
positive associations with each other (r 5 0.07-0.87, Supple-
mentary Table 9, available online at http://links.lww.com/PAIN/
A543). Items from the intermittent ICOAP subscale showed
strong correlations (r . 0.8, P , 0.05) with corresponding
constant ICOAP items.
3.3.1. Association between pressure pain detection
threshold and self-report scales or items
Each scale was negatively associated at a univariate level with
PPT (b 5 20.09 to 20.21, each P , 0.05 except intermittent-
ICOAP, P5 0.13). A significant proportion of variation in PPT was
explained by each scale alone (R2 values5 0.10-0.13, P, 0.05).
Individual items displayed negative associations with PPT
(Table 3). After excluding intermittent pain (to avoid item
redundancy), a single item was selected to represent each of 8
remaining traits: fatigue, cognitive impact, pain distribution,
anxiety, depression, catastrophic thinking, neuropathic-like,
and constant pain (Table 3).
3.4. Validation of selected items
The 8 selected items displayed a Cronbach alpha (a) of 0.80, and
predicted proximal tibia PPT in a multiple regression model (R25
0.18, P , 0.05) more than did any trait specific scale or item.
Competing 2- and 3- factor models for these items were not
identified in the exploratory group and a specified 2-factor CFA
models did not significantly alter the 1-factor model, supporting
the 1-factor model. The 1-factor model also showing the best fit
to data from the Confirmatory group (root-mean-square error of
approximation 5 0.07; weighted root-mean-square residual 5
0.5; X2(df) 5 43(20)). Each item was significantly associated with
the single latent construct, interpreted as representing central
mechanisms of knee pain (Table 4).
The latent construct was associated with PPT (b520.27; SE
5 0.07; P, 0.001), independent of each scale from which items
were derived (Table 5). Associations between each selected item
and PPT were reduced and lacked significance after adjusting for
derived host scale scores (Supplementary Table 10, available
online at http://links.lww.com/PAIN/A543), except for the neuro-
pathic item on cold or heat on the area causing pain (b520.21,
SE5 0.08, P, 0.05) and the anxiety item “I get sudden feelings
of panic” (b 5 20.19, SE 5 0.09, P , 0.05), where the
relationship remained significant after adjusting for derived host
scale scores.
The latent construct explained a higher proportion of PPT
variance at the proximal tibia (R25 0.17, SE5 0.05, P, 0.001),
compared with that explained by any multi-item, trait-specific
questionnaire (R2 values 5 0.10-0.13, P , 0.05). The latent
construct also explained a high proportion of PPT variance at the
sternum (R25 0.20, SE5 0.05, P, 0.001), medial- (R2 5 0.34,
SE 5 0.05, P , 0.001), and lateral- (R2 5 0.24, SE 5 0.05; P ,
0.001) joint line. The latent construct was also associated with
knee pain severity (b 5 0.66; SE 5 0.05, P , 0.001), but not
radiographic scores (b 5 0.10; SE 5 0.07; P 5 0.160). The
relationship between the latent construct and PPT remained
significant even when radiographic scores, or pain severity, were
accounted for within the model (b 5 20.267; SE 5 0.07; P ,
0.001, and b 5 20.213; SE 5 0.06; P , 0.001, respectively).
The final best-fitting MIMIC model was a good fit to the data
(comparative fit index 5 0.943, Tucker–Lewis index 5 0.924;
root-mean-square error of approximation 5 0.050; weighted
root-mean-square residual 5 0.761; x2(df) 5 53.696 (33)). An
effect of BMI on the latent construct (b5 0.310, SE5 0.064, P,
0.001), but not sex (b 5 0.073, SE 5 0.070, P 5 0.295) nor age
(b 5 20.064, SE 5 0.069, P 5 0.357), was observed. Item-
specific effects for age (anxiety item: b 5 20.114, SE 5 0.055,
P 5 0.038) and BMI (depression item: b 5 0.135, SE 5 0.056,
P 5 0.015) were observed, but not for sex.
All secondary analyses using PPT at the index knee joint line or
sternum produced similar results to those using proximal tibia
PPT (Supplementary Tables 11 and 12, available online at http://
links.lww.com/PAIN/A543).
4. Discussion
In the current study, we identified 8 key traits, represented by 8
self-report items which together load onto a single construct
interpreted as reflecting central pain mechanisms in people with
knee pain. The 8 key traits were anxiety, depression, catastroph-
izing, neuropathic-like pain, fatigue, sleep disturbance, pain
distribution, and cognitive impact. Items representative of these
traits displayed high face validity based on expert opinion and
external validity by association with high pain sensitivity (low PPT)
at a site distal to the index knee, indicative of central
sensitization.31 These items might identify people whose knee
pain could benefit from treatments directed towards central
mechanisms.
Consistent with previous studies, we show that in individuals
with knee pain, associations exist between reduced PPTs and
increased scores on each of the 8 traits.7,30,45 Scores for each
trait were significantly correlated with the other traits, consistent
with a single latent construct, but a combination of the 8 traits
explained more variation in PPTs compared with any originating
questionnaire alone. We conclude that a combination of items
from across these 8 traits might indicate the extent of central pain
augmentation in people with knee pain. Consistent with previous
reports where between 5% and 20% of PPT variance was
explained by demographic, psychological, and/or genetic varia-
bles,19,76 the latent construct explains a significant proportion of
PPT variance. This provides evidence of validity as a model of
central sensitisation, but further research would be required to
determine whether the identified construct explains a greater
proportion of variation in other indices of central sensitisation, or
variation in pain relief in response to interventions that target
central sensitisation in people with knee pain.66
Augmented central pain processing is well recognised in
people with chronic WSP but can be more difficult to identify
when pain is focussed on a specific anatomical site such as the
knee. Further researchmight define whether the traits identified in
the current study of people with knee pain, might also reflect
augmented central pain processing in people with pain at another
Month 2018·Volume 00·Number 00 www.painjournalonline.com 5
Table 3
Item performance for each statistical criteria to select “best performing items” across traits.
Shortlisted items (items 5 19)† Traits Scale—ESEM construct
(loading score)
Expert
rating (k*)
Respondents endorsing
scores >0 (%)
Correlation with log-PPTs
(Spearman rho)
1. “I look forward with enjoyment to
things”
Depression HADS—depression (0.93) 0.71 54 20.12*
2. “I still enjoy the things I used to
enjoy”
Depression HADS—depression (0.82) 0.64 75 20.15*
3. “I can’t seem it keep it out of my
mind”
Catastrophic
thinking
PCS—rumination (0.92) 0.71 52 20.11
4. “I keep thinking about how much
it hurts”
Catastrophic
thinking
PCS—rumination (1.08) 0.83 59 20.13*
5. “I feel I can’t go on” Catastrophic
thinking
PCS—helplessness (0.99) 0.78 24 20.09
6. “I feel I can’t stand it anymore” Catastrophic
thinking
PCS—helplessness (0.93) 0.78 56 20.09
7. Is cold or heat (bath water) in this
area occasionally painful?
Neuropathic
symptoms
MPDQ—evoked symptoms
(0.85)
0.73 43 20.23*
8. Over the past month, in your
most painful knee, is light touching
(clothing, a blanket) in this area
painful?
Neuropathic
symptoms
MPDQ—evoked symptoms (0.56) 0.79 40 20.21*
9. Over the past month, do you
have a tingling or prickling
sensation in the area of your most
painful knee “pain” (like crawling
ants or electrical tingling)?
Neuropathic
symptoms
MPDQ—spontaneous symptoms
(1.15)
0.66 50 20.09
10. In the past week, how much
has your knee pain that comes and
goes affected your sleep?
Intermittent pain
experience
Intermittent ICOAP—somatic
symptoms (0.71)
0.64 56 20.17*
11. In the past week, how upset or
worried have you been by your knee
pain that comes and goes?
Intermittent pain
experience
Intermittent ICOAP—psychological
symptoms (0.76)
0.69 71 20.14*
12. In the past week, how
frustrated or annoyed have you
been by your constant knee pain?
Constant pain
experience
Intermittent ICOAP—psychological
symptoms (0.78)
0.60 76 20.17*
13. In the past week, how upset or
worried have you been by your
constant knee pain?
Constant pain
experience
Constant ICOAP—psychological
symptoms (0.90)
0.78 69 20.16*
14. In the past week, how much
has your constant knee pain
affected your sleep?
Constant pain
experience
Constant ICOAP—somatic
symptoms (0.88)
0.78 68 20.21*
15. “I get a sort of frightened
feeling as if something awful is
about to happen”
Anxiety HADS—anxiety (0.83) 0.69 60 20.08
16. “I get sudden feelings of panic” Anxiety HADS—anxiety (0.82) 0.61 53 20.19*
17. Knee pain plus other pain below
the waist
Pain distribution — 0.81 52 20.14*
18. Does your pain or other bodily
symptoms stop you from
concentrating on what you are
doing?
Cognitive impact — 0.71 74 20.18*
19. In the past month, did you feel
tired on most days?
Fatigue — 0.61 96 20.15*
Items in bold represent items selected as “best performing items.”
Items originating from established scales showed the highest significant (P, 0.05) associations with each identified latent construct during ESEM analysis. Domains measured by singular items (item-specific domains) not
entered into ESEM.
Fatigue, pain distribution, and cognitive impact measured by singular items.
* P , 0.05 (Bonferroni corrected).
† Items presented (items 5 19) were rated by experts to show relevance to centrally augmented mechanisms after expert rating (k* . 0.60).
ESEM, exploratory structural equation modelling; HADS, Hospital Anxiety and Depression scale; ICOAP, Intermittent and Constant Osteoarthritis Pain scale; MPDQ, Modified PainDETECT Questionnaire; PCS, Pain
Catastrophizing Scale; PPT, pressure pain detection threshold.
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site. Several items identified in this study represent the emotional
component of pain, and shared mechanisms within the CNS
might underpin associations with central pain augmentation.48,71
Cognitive difficulties or “brain fog” are frequent complaints of
people with musculoskeletal pain,50 and experimental pain
impairs performance in cognitive tasks.20,75 Neuropathic-like
pain is also prevalent in people reporting knee OA pain and has
been associated with reduced PPTs.39,49 Sleep disruption can
lead to augmented central pain processing,34 and fatigue is
strongly associated with musculoskeletal pain severity.67 Asso-
ciation between WSP and central mechanisms has been
described previously.10 We extend these findings to show that
higher numbers of painful sites, and pain below the waist other
than knee pain, were each associated with reduced PPT. A
minority of participants in our study satisfied ACR criteria for WSP
and wemight have lacked sufficient power to detect associations
of WSP with PPT. However, our data indicate that central
mechanisms might still contribute to pain in people with multisite
pain who do not satisfy classification criteria for WSP.
Strength of association between each selected item and PPT
was reduced after adjustment for originating questionnaire-
derived score, suggesting at least partial mediation by the host
construct. However, associations between PPT and items
addressing neuropathic-like pain in response to cold or heat, or
addressing feelings of panic remained statistically significant even
after adjustment for the derived painDETECT and HADS-anxiety
scores. These itemsmight have specific associations with central
mechanisms over and above representing neuropathic-like pain
or anxiety, respectively.
The “central mechanisms” construct identified here explains
slightly more PPT variance than that explained by any of the
individual traits. Association between PPTs and the “central
mechanisms” construct was found to be not explained by
originating questionnaire-derived scores, disease severity, or
pain severity. Together, these findings support use of a composite
tool to identify the extent of central pain augmentation in people
with knee pain rather than individual assessment of each trait on
a case-by-case basis in clinical practice. Identification of these
central pain mechanisms might well have prognostic relevance,
and further work should assess whether central pain mecha-
nisms might at least in part, explain the predictive values of other
prognostic tools such as the Orebro Musculoskeletal Pain
Screening Questionnaire,44 or StartBACK.38 Items reflecting
psychological distress, similar to those included in the current
study, are included within these scales. However, the Orebro and
StartBACK questionnaires do not assess other key traits that we
have identified in the current study, such as somatic traits of
neuropathic-like symptoms and pain distribution.
Associations between the “central mechanisms” construct
and increased BMI during MIMIC analysis support previous work
in other chronic pain conditions, which demonstrate significant
associations between BMI and other markers of central pain
mechanisms.26,58 Addressing central pain mechanisms using
nonpharmacological and/or pharmacological approaches is likely
to improve pain treatment response, physical function, and other
important outcomes for the individual.32 Further research should
explore whether the core construct discovered here can predict
pain outcome or response to treatment or help improve health
care efficiency by directing targeted treatments. Randomized
control trials might explore responsiveness of individuals with
knee pain to novel or repurposed pharmacological and non-
pharmacological therapies targeted to traits of psychological
distress, neuropathic-like pain, and somatic disturbances iden-
tified in the current work.21 Longitudinal research might explore
whether traits, or the central construct identified in the current
Table 4
Standardized item loadings for the 8 selected items in a single factor model in exploratory and confirmatory subgroups.
Item Domain Exploratory sample (n 5 166) Confirmatory sample (n 5 154)
“I get sudden feelings of panic” Anxiety 0.53* 0.49*
“I still enjoy the things I used to enjoy” Depression 0.57* 0.52*
“Over the past month, in your most painful knee,
is cold or heat (bath water) in this area
occasionally painful?”
Neuropathic symptoms 0.52* 0.57*
“In the past month, did you feel tired on most
days?”
Fatigue 0.62* 0.61*
“Does your pain or other bodily symptoms stop
you from concentrating on what you are doing?”
Attention to pain 0.79* 0.81*
“Knee pain plus other pain below waist” Pain distribution 0.44* 0.40*
“I keep thinking about how much it hurts” Catastrophising 0.57* 0.58*
“In the past week, how much has your constant
knee pain affected your sleep?”
Sleep 0.66* 0.69*
* P , 0.05.
Table 5
Prediction of proximal tibia PPT by identified factor
independent of derived host scale scores (host scale score
minus selected items score).
Scales adjusted for b SE P
Unadjusted model 20.27 0.07 ,0.001
Constant pain—ICOAP 20.19 0.07 0.01
Neuropathic pain—PainDETECT 20.21 0.07 0.01
Catastrophizing—PCS 20.28 0.08 ,0.001
Anxiety—HADS 20.24 0.07 0.001
Depression—HADS 20.26 0.08 0.001
The single latent construct identified through the 8 selected items, interpreted as “central mechanisms of
knee pain,” was associated with log-transformed pressure pain detection thresholds (PPTs) distal (proximal
tibia) from the index knee in an unadjusted model, and in models where total scores derived from each of the
originating scales (scale summary score minus selected item) were adjusted for standardized coefficients (b)
presented.
HADS, Hospital Anxiety and Depression scale; ICOAP, Intermittent and Constant Osteoarthritis Pain scale;
PCS, Pain Catastrophizing Scale.
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study might predict better treatment response to such centrally
targeted treatments. Conversely, traits identified in this study
might indicate a central knee pain component which might not
necessarily respond to a treatment that targets peripheral
nociceptive drive.48 High catastrophizing predicted worse pain
improvement after total knee arthroplasty in a previous study.62
This study is not without its limitations. Participant selection
within KPIC for PPT assessments was weighted towards an early
knee pain sample (pain for ,3 years), and a high proportion had
radiographic Kellgren and Lawrence scores,2. Previous studies
have demonstrated a lack of association between PPTs and
symptom duration in individuals with OA knee pain,55 but further
research should determine whether our findings can be
generalised to people with longer symptom duration or more
severe OA structural change. The traits analysed were limited to
those included within the KPIC baseline survey, and initial
screening by the researchers may have allowed subjective bias
during the initial stage of item selection. All experts involved within
the current study originated from a single centre in the United
Kingdom. Their breadth of expertise reflected multiple disciplines
involved in the treatment and research of knee pain, but it is
possible that additional traits might further contribute to the
identification of pain mechanisms in people with knee pain. The
current work is also limited because of the cross-sectional
approach used, and longitudinal studies might help disentangle
the nature of the relationship between pain severity, peripheral
pathology, PPTs, and traits identified in the current study.
We used only 1 modality of quantitative sensory testing
assessment—PPT—which was both used for item selection
and other validation analysis. The PPT has consistently been
associated with knee pain in previous studies and displays good
measurement properties in people with knee pain.53 Our study
design selected proximal tibia PPT, distal to the index knee, as
a primary outcome index of central sensitisation. Index knee joint
line PPT displayed higher reliability than proximal tibia PPT, but is
likely to be dependent on peripheral and central sensitization.55
Pressure pain detection thresholds at remote sites displayed
lower reliability than other sites and are less strongly associated
with OA pain when compared with PPTs from sites distal to the
affected joint.55,73 Further work is needed to confirm the specific
central pathways that drive distal and remote pain sensitivity in
knee OA.
Previous work has demonstrated associations between other
modalities for accessing central pain mechanisms (eg, temporal
summation or brain imaging), and self-report questionnaires
about pain distribution, neuropathic-like symptoms, catastroph-
izing, sleep disturbance, fatigue, depression, and anxi-
ety.1,9,13,17,45 These other modalities for assessing central
mechanisms, especially those with higher reliability than PPTs,
might produce more confident estimates of associations with the
construct identified here.41
Further research should determine whether the central
construct identified in the current study might also predict these
other indices of central pain mechanisms. Central mechanisms
and their self-report correlates present across a spectrum, rather
than dichotomous presence or absence, and further research
should define clinical thresholds that might predict or represent
important response to treatment.
In conclusion, we show that 8 individual phenotypic traits, as well
as a single overall construct (interpreted as “central pain mecha-
nisms”) represented by 8 items, are correlates of a PPT index for
centrally augmented pain in individuals with knee pain. These items
might be combined to identify the extent of central pain
augmentation in people with knee pain. Future research should
determine whether a “central pain mechanisms” questionnaire can
predict prognosis or treatment responses in people who present in
a clinical setting with a local pain problem such as knee pain.
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